News Quantified

HOLX – hologic, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio

HOLX Stock Slips on Q1 Earnings and Revenue Miss, Margins Crash [Yahoo! Finance]

Hologic (NASDAQ:HOLX) had its "hold (c)" rating reaffirmed by analysts at Weiss Ratings.

Hologic Announces Financial Results for First Quarter of Fiscal 2026

Analysts consider potential Qiagen deal amid reported strategic review [Yahoo! Finance]

-0.1%

MISS

0.1%

BEAT

2.8%

BEAT

-5.4%

BEAT

Form 8-K HOLOGIC INC For: Feb 05

Form 4/A HOLOGIC INC For: Jan 30 Filed by: De Walt Diana

Form 4 HOLOGIC INC For: Jan 30 Filed by: De Walt Diana

Form 10-Q HOLOGIC INC For: Dec 27

Form DEFA14A HOLOGIC INC

Top News Gainers

3/19 CDC, public labs have conducted 37,824 COVID-19 tests [MarketWatch] 6.5%

3/18 CDC, public health labs have conducted at least 31,000 tests [MarketWatch] 5.8%

4/23 Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 5.1%

4/2 Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Needham & Company LLC from $62.00 to $52.00. They now have a "buy" rating on the stock. 4.8%

4/8 Hologic, Inc. (NASDAQ: HOLX) had its "outperform" rating re-affirmed by analysts at William Blair. 4.7%

11/20 Clayton, Dubilier & Rice to Acquire Market-Leading Medical Aesthetics Technology Company 4.3%

3/9 Form 4 HOLOGIC INC For: Mar 05 Filed by: HANTSON LUDWIG 4.0%

4/7 Form 8-K HOLOGIC INC For: Apr 07 2.9%

3/26 Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Barclays PLC from $51.00 to $43.00. They now have an "equal weight" rating on the stock. 2.8%

1/31 Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at TheStreet from a "c" rating to a "b+" rating. 2.7%

Top News Decliners

3/17 Form 8-K HOLOGIC INC For: Mar 16 -11.4%

3/11 Form 4 HOLOGIC INC For: Mar 09 Filed by: CRAWFORD SALLY -9.9%

4/30 Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Needham & Company LLC from $52.00 to $60.00. They now have a "buy" rating on the stock. -8.1%

3/20 CDC, public health labs performed at least 44,000 COVID-19 tests [MarketWatch] -5.9%

11/7 Hologic, Inc. (HOLX) CEO Steve MacMillan on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -5.3%

10/1 Hologic CEO Steve MacMillan to Ring Nasdaq Opening Bell on October 2 -4.5%

3/10 Form 8-K HOLOGIC INC For: Mar 05 -4.5%

8/14 Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Argus to $62.00. They now have a "buy" rating on the stock. -4.4%

3/5 German Lab Demonstrates Feasibility to Detect SARS-Coronavirus-2 (SARS-CoV-2) Using Hologic’s Panther Fusion® System -4.3%

3/21 CDC, public health labs have tested at least 54,205 Americans for coronavirus [MarketWatch] -3.7%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day